Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Novo Nordisk is the market leader: Ozempic (weekly injection for type 2 diabetes) Wegovy (higher-dose weekly injection for obesity) Rybelsus ( Oral tablets for diabetes Oral tablets for weight management is in phase 3 trials) Eli Lilly is the other major player: Mounjaro (weekly injection for type 2 diabetes) Zepbound (higherdose weekly injection for obesity) This duopoly meant that both stocks had an incredible run-up from 2020 to 2024
Putting the Pharmacy Cost Issue into Perspective Humira was the #1 drug in terms of spending for many health plans beating out every diabetes or weight-loss drug on the market
Track Your Semaglutide Results and Optimize Your Weight Loss Tracking your semaglutide results isn't about focusing too much on numbers
Bhatta, S
its necessary to look at the whole picture, collectively
US$ 24.08
US$ 24.87
US$ 25.96
